Published in BMJ on October 05, 2002
On communication--editors and reporters should not be blamed. BMJ (2002) 0.75
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA (2002) 80.37
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med (1995) 11.08
Efficacy of a Cancer Research UK communication skills training model for oncologists: a randomised controlled trial. Lancet (2002) 5.17
What is newsworthy? Longitudinal study of the reporting of medical research in two British newspapers. BMJ (2002) 4.05
Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst (2006) 7.29
Multidisciplinary teams in cancer care: are they effective in the UK? Lancet Oncol (2006) 3.79
No news is not good news: information preferences of patients with cancer. Psychooncology (1995) 2.95
Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial. Lancet Oncol (2008) 2.34
Recruitment to multicentre trials--lessons from UKCTOCS: descriptive study. BMJ (2008) 2.10
Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study. Lancet Oncol (2013) 2.02
Lay understanding of terms used in cancer consultations. Psychooncology (2003) 1.76
Factors affecting patient and clinician satisfaction with the clinical consultation: can communication skills training for clinicians improve satisfaction? Psychooncology (2003) 1.73
Intentional and non-intentional non-adherence to medication amongst breast cancer patients. Eur J Cancer (2006) 1.66
Pulmonary metastasectomy in colorectal cancer: the PulMiCC trial. Thorax (2011) 1.65
Quality of life of postmenopausal women in the ATAC ("Arimidex", tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for early breast cancer. Breast Cancer Res Treat (2006) 1.61
Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort. Lancet Oncol (2010) 1.60
Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study. Psychooncology (2004) 1.48
Communication about sexual problems and sexual concerns in ovarian cancer: a qualitative study. West J Med (2002) 1.40
Can communication skills training alter physicians' beliefs and behavior in clinics? J Clin Oncol (2002) 1.40
Bone-related complications and quality of life in advanced breast cancer: results from a randomized phase III trial of denosumab versus zoledronic acid. Clin Cancer Res (2012) 1.26
Pulmonary metastasectomy in colorectal cancer: the PulMiCC trial. J Thorac Oncol (2010) 1.19
Information needs and experiences: an audit of UK cancer patients. Eur J Oncol Nurs (2005) 1.17
Epoetin alfa improves quality of life in patients with cancer: results of metaanalysis. Cancer (2004) 1.17
Impact on mortality and cancer incidence rates of using random invitation from population registers for recruitment to trials. Trials (2011) 1.17
Psychosocial and supportive-care needs in high-grade glioma. Lancet Oncol (2008) 1.15
Systematic review of supportive care needs in patients with primary malignant brain tumors. Neuro Oncol (2012) 1.01
Pain outcomes in patients with advanced breast cancer and bone metastases: results from a randomized, double-blind study of denosumab and zoledronic acid. Cancer (2012) 0.99
The effects of hormone therapy on cognition in breast cancer. J Steroid Biochem Mol Biol (2003) 0.95
The quality of life of men with locally advanced prostate cancer during neoadjuvant hormone therapy: data from the Medical Research Council RT01 trial (ISRCTN 47772397). BJU Int (2006) 0.86
Patients' decision-making in a UK specialist centre with high mastectomy rates. Breast (2008) 0.86
Sun-protective behaviors in families at increased risk of melanoma. J Invest Dermatol (2007) 0.84
Does endocrine therapy for the treatment and prevention of breast cancer affect memory and cognition? Eur J Cancer (2007) 0.82
Psychosocial Factors Associated With Withdrawal From the United Kingdom Collaborative Trial of Ovarian Cancer Screening After 1 Episode of Repeat Screening. Int J Gynecol Cancer (2015) 0.82
Psychosexual function and impact of gynaecological cancer. Best Pract Res Clin Obstet Gynaecol (2006) 0.80
Learning how to communicate in cancer settings. Support Care Cancer (2005) 0.80
Group acupuncture to relieve radiation induced xerostomia: a feasibility study. Acupunct Med (2009) 0.79
Pain outcomes in patients with bone metastases from advanced cancer: assessment and management with bone-targeting agents. Support Care Cancer (2014) 0.78
Information provision for patients by breast cancer teams about the side-effects of hormone treatments. Eur J Cancer (2006) 0.78
Group recruitment sessions enhance patient understanding in a small multi-centre phase III clinical trial. Contemp Clin Trials (2011) 0.78
Doctors' communication of trust, care, and respect: details of paper were incorrect. BMJ (2004) 0.75
Specialist breast care and research nurses' attitudes to adjuvant chemotherapy in older women with breast cancer. Eur J Oncol Nurs (2011) 0.75
Introduction to the sessions on 'Debate: extended follow-up of breast cancer patients in clinic wastes time for both patients and doctors'. Breast Cancer Res (2008) 0.75
Supportive follow-up in patients treated with radical intent for high-grade glioma. CNS Oncol (2012) 0.75